KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Total Non-Current Liabilities (2016 - 2025)

West Pharmaceutical Services' Total Non-Current Liabilities history spans 16 years, with the latest figure at $869.4 million for Q1 2025.

  • For Q1 2025, Total Non-Current Liabilities changed N/A year-over-year to $869.4 million; the TTM value through Mar 2025 reached $869.4 million, changed N/A, while the annual FY2023 figure was $890.0 million, 1.1% up from the prior year.
  • Total Non-Current Liabilities for Q1 2025 was $869.4 million at West Pharmaceutical Services, down from $890.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $940.2 million in Q4 2021 and bottomed at $812.1 million in Q3 2022.
  • The 4-year median for Total Non-Current Liabilities is $880.3 million (2022), against an average of $884.8 million.
  • The largest annual shift saw Total Non-Current Liabilities rose 17.33% in 2021 before it fell 6.37% in 2022.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $940.2 million in 2021, then decreased by 6.37% to $880.3 million in 2022, then grew by 1.1% to $890.0 million in 2023, then fell by 2.31% to $869.4 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Total Non-Current Liabilities are $869.4 million (Q1 2025), $890.0 million (Q4 2023), and $880.3 million (Q4 2022).